Phase I-II trial of anthracenedicarboxaldehyde in patients with refractory adult acute leukemia.
D000208:Acute Disease; D058186:Acute Kidney Injury / Q000139:chemically induced; D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000009:adverse effects / Q000627:therapeutic use; D004064:Digestive System / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged
D000873:Anthracenes; C031404:bisantrene